Volume 2, Issue 10 : Risks and Benefits of SGLT-2 Inhibitor Agents
e-Diabetes Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with diabetes. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 2, Issue 10)
Nurses and health care professionals involved in the care of patients with diabetes.
After participating in this activity, the participant will demonstrate the ability to describe new findings in:
- Describe the glucose, weight, and blood pressure lowering effects of SGLT-2 inhibitors and their persistence over time.
- Discuss the cardiovascular benefits reported with the use of SGLT-2 inhibitors.
- Summarize the risks of SGLT-2 inhibitors, including diabetic ketoacidosis and bone fractures.
Anne Peters, MD
Keck School of Medicine of the University of Southern California
Director, USC Clinical Diabetes Program
Los Angeles, California
- 1.00 ANCC
- 1.00 Attendance